Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 215 for “"antithrombotic"”.
-
Antithrombotic agents under flow conditions
… inhibition by two distinct classes of antithrombotic agents: anti-platelet antibodies and anticoagulants, including unfractionated heparin (UFH), low molecular weight heparin (LMWH) and hirudin. <br></br><br></br>Increasing flow rates increased TG, which was higher in the presence of …
-
Development of Novel Antidote Controlled Antithrombotic Aptamers
… potentially lead to the development of effective antithrombotic therapies. With an ever-increasing number of people taking multiple medications, the need to safely administer drugs and limit unintended side effects has never been greater. Antidote control remains the most direct means to …
-
A Microfluidic Approach For Evaluating Novel Antithrombotic Targets
… growth and to evaluate their potential as safer antithrombotic drug targets. The use of low level of corn trypsin inhibitor allowed the study of the contact pathway on collagen/kaolin surfaces with minimally disturbed whole blood sample and we demonstrated the sensitivity of this assay to …
-
Platelets and antithrombotic therapies in coronary artery disease
Contains fulltext : 142567.pdf (Publisher’s version ) (Open Access)
-
Dermatan Sulfate: A New Concept in Antithrombotic Therapy
… that<br />dermatan sulfate is an effective antithrombotic agent and<br />support the conclusion that the catalysis of thrombin<br />inhibition by dermatan sulfate/heparin cofactor II provides<br />a more effective pathway for preventing thrombus formation and<br />thrombus growth than the …
-
Development of RNA Aptamers and Antidotes as Antithrombotic Therapeutics
… of morbidity and mortality in the western world. Antithrombotics are commonly prescribed as prophylactic medications or as rapid onset anticoagulants in acute care clinical settings. Although a number of antithrombotics are clinically available, their use is limited by immunogenicity, toxicity, …
-
Assessment of antithrombotic drugs in vivo and ex vivo
… inhibit platelet function and may be effective antithrombotic agents can only be demonstrated in clinical studies. Unfortunately, since the stimuli which cause thrombosis in patients are likely to vary extensively and since the mode of action of these drugs on such stimuli, although not …
-
ASSESSING DRUG DEVELOPMENT PROPORTIES OF ANTITHROMBOTIC AND ANTI - CANCER AGENTS
… wild-type ICR male mice and rats to identify antithrombotic activity. The current proposed studies will provide a comprehensive understanding of the pharmacokinetics of these novel antithrombotic and anticancer agents in vitro, ex-vivo, and in vivo levels. Moreover, these studies' outcomes …
-
ANTITHROMBOTIC THERAPY IN PATIENTS WITH SURGICAL BIOPROSTHETIC AORTIC VALVE REPLACEMENT
… the evidence behind current recommendations for antithrombotic therapy after bioprosthetic AVR, identify evidence gaps, and present the design a randomized trial that aims to address some of these evidence gaps. Chapter 1 introduces each included study with a brief summary. Chapter 2 is a …
-
Interaction of detergent sclerosants with coagulation, antithrombotic and fibrinolytic mecanisms
… (STS) and polidocanol (POL), on coagulation, antithrombotic and fibrinolytic mechanisms were investigated in vitro. All samples were spiked with each sclerosant at therapeutic concentrations. Coagulation was investigated in clotting tests and functional assays for clotting factors in plasma. …
-
The Anticoagulant and Antithrombotic Properties of Human Prothrombin Fragment 1.2
… human prothrombin F1.2 has anticoagulant and antithrombotic properties.</p>
-
Effect of novel antithrombotic agents on platelet aggregation under flow conditions
Epi-fluorescence video microscopy and digital image processing were used to evaluate the effects of three novel anti-platelet agents namely GT-12/I.2HBr (GT-12/I), A4.2HBr and IC, a series of compounds containing the $-$3-carboxylic acid piperidine moiety as their functional group, on platelet …
-
Antithrombotic Peptide Delivery from Glow-Discharge Plasma-Coated Controlled Release Matrices
A novel polymeric matrix system has been developed to deliver agents to block platelet adhesion or inhibit thrombin activation on implanted biomaterials. The base material of the system used was BioSpan®, a medical-grade polyether-urethane urea (PEUU) elastomer, which contained a dispersion of an …
-
Balancing risks and benefits in the optimization of oral antithrombotic therapy
Contains fulltext : 159895.pdf (Publisher’s version ) (Open Access)
Page 1 of 11